Soluble Aβ oligomers impair both vesicular and axonal BDNF trafficking resulting in disruption of BDNF signaling, which underlies the synaptic dysfunction displayed in AD (Poon et al., 2011; Seifert et al., 2016). This evidence concerns the gene BDNF and Alzheimer disease.